AI-classified response stance
Action Planned
AI-generated response summary• The Medicines and Healthcare products Regulatory Authority (MHRA) communicated information about the risk of severe and fatal burns with emollient creams in December 2018.
• The MHRA convened a stakeholder group to design and optimise educational resources for healthcare professionals and the public.
• The stakeholder group is developing a toolkit of resources for patients, carers, and healthcare professionals, with an official launch planned for 2020.
View full response
From Nadine Donies MP Department Parliamentary Under Secrelary of State for Mental Health; Suicide Prevention and Patient Safety of Health & Social Care 39 Victoria Street London SW1H OEU Your Ref: AAHIRE152021 020 7210 4850 Our Ref: PFD-1197497 Mrs Margaret J Jones HM Assistant Coroner, Staffordshire (South) 1 Staffordshlre Place Stafford ST16 2LP 2 | Jt January 2020 Mc &o; Thank you for your correspondence of 22 November 2019 to Matt Hancock about the death of Mrs Maureen Milton: am replying as Minister with responsibility for patient safety: Firstly, would like to say how saddened was to read of the tragic circumstances of Mrs Mllton's death: offer my sincere condolences to Mrs Milton's family and loved ones. In preparing the response to your report, Departmental officials have taken advice from the Medicines and Healthcare products Regulatory Authority (MHRA) which is an executive agency of the Department of Health and Social Care and is responsible for ensuring that medicines and medical devices available in the UK meet applicable standards of safety, quality and efficacy: The matters of concern in your report are that there Is a lack of awareness among healthcare professionals, patients and their carers, of the fire risk associated with the Use of paraffin-based emollient creams; and that paraffin is found in a number of prescribed creams as well as creams such as moisturisers that are readily available over the counter: The MHRA advises that it most recently communicated information about the risk of severe and fatal bums with paraffin-containing and paraffin-free emollients in December 2018 through a press release and an article in Safety Update' . These communications resulted from an in-depth review of this issue by the MHRA's independent expert advisory committee, the Commission on Human Medicines (CHM): Following that review; the MHRA has convened a stakeholder group that includes representatives from the service, healthcare professionals and their representative btps www_gov ukldng-safcty-updatelemollicnts-new-infomation-aboutisk-of-sevcre-und-fatel-bums-with: panin-conlaining-and panffn_free cmollicnts Drug fire
bodies, organisations that provide guidance to health and social care workers, patient ropresentatives and organisations that speak for relevant patient populations such as the National Eczema Society: The stakeholder group is designing and optimising sustainable and educational resources for healthcare professionals and the public and their tehog ondistibutoancaoteges toensure these are impactful and maintain long-term awareness of the risk of emollient creams. am advised that the group has met twice, most recently on 10 December 2019,and is working towards producing a toolkit of resources for patients, their carers' , healthcare professionals, health organisations and healthcare Professional educators; The Government welcomes plans by the MHRA to officially launch the toolkit in 2020 This will be accompanied by a MHRA press release and Stakeholders will propagate the key messages through their networks at the same time. hope this reply is helpful Thank you for bringing these concerns to my attention Na_ NADINE DORRIES ~nJ